Chapter 1 Introduction
1.1 Report Description
1.2 Market Segmentation
1.3 Research Methodology
Chapter 2 Executive Summary
Chapter 3 Market Overview
3.1 Introduction
3.2 Market Drivers
3.2.1 Rise in incidences of target diseases such as cancer and viral infections
3.2.2 Aging of the global population
3.2.2.1 Global Rate of Aging Population
3.2.3 Increase in the development of vaccines
3.2.3.1 Pipeline Vaccines and Research Phase
3.2.4 Technological advancements in product design
3.2.5 Impact Analysis of Market Drivers
3.3 Market Restraints
3.3.1 Lack of regulatory approval for intravenous insulin infusion pumps in key markets such as the U.S.
3.3.2 Risk associated with use of needles
3.3.3 Impact Analysis of Market Restraints
3.4 Market Opportunities
3.4.1 Large target patient pool and rise in disposable income in emerging economies
3.5 Porters Five Force Analysis for the Global Intravenous Access Devices Market
3.5.1 Bargaining Power of Suppliers
3.5.2 Bargaining Power of Buyers
3.5.3 Threat of Substitutes
3.5.4 Threat of New Entrants
3.5.5 Competitive Rivalry
3.6 Market Attractiveness Analysis
3.6.1 Market Attractiveness Analysis: Global Intravenous Access Devices Market, by Geography
Chapter 4 Global Intravenous Access Devices Market, by Product Type
4.1 Overview
4.1.1 Global Intravenous Access Devices Market Revenue, by Product Type, 2011-2019 (USD Billion)
4.1.2 Comparative Analysis: Global Intravenous Access Devices Market, by Product Type, 2012 & 2019 (Value %)
4.2 Intravenous Needles
4.2.1 Global Intravenous Needles Market Revenue, 2011 - 2019 (USD Billion)
4.3 Intravenous Catheters
4.3.1 Global Intravenous CatheterMarket Revenue, by Type, 2011 - 2019 (USD Billion)
4.3.2 Midline Peripheral Catheters
4.3.2.1 Global Midline Peripheral Catheter Market Revenue, 2011 - 2019 (USD Billion)
4.3.3 Central Catheters
4.3.3.1 Global Central CathetersMarket Revenue, by Type, 2011 - 2019 (USD Billion)
4.3.3.2 Peripherally Inserted Central Catheters (PICC)
4.3.3.2.1 Global Peripherally Inserted Central Catheter Market Revenue, 2011 - 2019 (USD Billion)
4.3.3.3 Centrally Inserted Central Catheters
4.3.3.3.1 Global Centrally Inserted Central Catheter Market Revenue, 2011 - 2019 (USD Billion)
4.4 Intravenous Infusion Pumps
4.4.1 Global Intravenous Infusion PumpsMarket Revenue, by Type, 2011 - 2019 (USD Billion)
4.4.2 Insulin infusion Pumps
4.4.2.1 Global Intravenous Insulin infusion Pumps Market Revenue, 2011 - 2019 (USD Billion)
4.4.3 Parenteral Feeding Infusion Pumps
4.4.3.1 Global Parenteral Feeding Infusion Pumps Market Revenue, 2011 - 2019 (USD Billion)
4.4.4 Patient Controlled Analgesia (PCA) Infusion Pumps
4.4.4.1 Global Patient Controlled Analgesia (PCA) Infusion Pumps Market Revenue, 2011 - 2019 (USD Billion)
4.4.5 Syringe Infusion Pumps
4.4.5.1 Global Syringe Infusion Pumps Market Revenue, 2011 - 2019 (USD Billion)
Chapter 5 Global Intravenous Access Devices Market, by Geography
5.1 Overview
5.1.1 Global Intravenous Access Devices Market Revenue, by Geography, 2011 - 2019 (USD Billion)
5.1.2 Comparative Analysis: Global Intravenous Access Devices Market, by Geography, 2012 & 2019 (Value %)
5.2 North America
5.2.1 North America Intravenous Access Devices Market Revenue, 2011 - 2019 (USD Billion)
5.3 Europe
5.3.1 Europe Geriatric Population Statistics (Million), 1991 - 2011
5.3.2 Europe Intravenous Access Devices Market Revenue, 2011 - 2019 (USD Billion)
5.4 Asia-Pacific
5.4.1 Asia-Pacific Intravenous Access Devices Market Revenue, 2011 - 2019 (USD Billion)
5.5 Rest of the World (RoW)
5.5.1 Rest of the World (RoW) Intravenous Access Devices Market Revenue, 2011 - 2019 (USD Billion)
Chapter 6 Competitive Landscape
6.1 Market Share by Key Players, 2012 (%)
Chapter 7 Recommendations
7.1 Market Strategies for Success
7.1.1 Entrance into long term contract with medical services providers
7.1.2 Product innovations
7.1.3 Broadening of distribution network
7.1.4 Mergers and acquisitions
7.1.5 Investing in emerging markets
Chapter 8 Company Profiles
8.1 Baxter International
8.1.1 Company Overview
8.1.2 Financial Overview
8.1.3 Product Portfolio
8.1.4 Business Strategies
8.1.5 Recent Developments
8.2 B. Braun Melsungen AG
8.2.1 Company Overview
8.2.2 Financial Overview
8.2.3 Product Portfolio
8.2.4 Business Strategies
8.3 Becton, Dickinson & Company
8.3.1 Company Overview
8.3.2 Financial Overview
8.3.3 Product Portfolio
8.3.4 Business Strategies
8.3.5 Recent Developments
8.4 CareFusion Corporation
8.4.1 Company Overview
8.4.2 Financial Overview
8.4.3 Product Portfolio
8.4.4 Business Strategies
8.4.5 Recent Developments
8.5 Covidien Plc
8.5.1 Company overview
8.5.2 Financial overview
8.5.3 Product portfolio
8.5.4 Strategic overview
8.5.5 Recent developments
8.6 Fresenius Medical Care AG & Co. KGaA
8.6.1 Company Overview
8.6.2 Financial Overview
8.6.3 Product Portfolio
8.6.4 Strategic Overview
8.6.5 Recent Developments
8.7 Hospira, Inc.
8.7.1 Company Overview
8.7.2 Financial Overview
8.7.3 Product Portfolio
8.7.4 Business Strategies
8.8 Medtronic, Inc.
8.8.1 Company overview
8.8.2 Financial Overview
8.8.3 Product Portfolio
8.8.4 Business Strategies
8.8.5 Recent Developments
8.9 Smiths Medical
8.9.1 Company Overview
8.9.2 Financial Overview
8.9.3 Product Portfolio
8.9.4 Business Strategies
8.9.5 Recent Developments
8.10 Teleflex Incorporated
8.10.1 Company Overview
8.10.2 Financial Overview
8.10.3 Product Portfolio
8.10.4 Strategies
8.10.5 Recent Developments
List of Tables
TABLE 1 Market Snapshot: Global Intravenous Access Devices Market
TABLE 2 Impact Analysis of Market Drivers
TABLE 3 Impact Analysis of Market Restraints
TABLE 4 Global Intravenous Access Devices Market Revenue, by Product Type, 2011 – 2019 (USD Billion)
TABLE 5 Global Intravenous CatheterMarket Revenue, by Type, 2011 – 2019 (USD Billion)
TABLE 6 Global Central CatheterMarket Revenue, by Type, 2011 – 2019 (USD Billion)
TABLE 7 Global Intravenous Infusion PumpsMarket Revenue, by Type, 2011 – 2019 (USD Billion)
TABLE 8 Global Intravenous Access Devices Market Revenue, by Geography, 2011 – 2019 (USD Billion)
TABLE 9 Europe Geriatric Population Statistics (Million), 1991-2011
List of Figures
FIG. 1 Intravenous Access Devices Market Segmentation
FIG. 2 Global Intravenous Access Devices Market, by Product Type, 2012 (USD Billion)
FIG. 3 Global Rate of Aging Population
FIG. 4 Porter’s Five Force Analysis: Global Intravenous Access Devices Market
FIG. 5 Market Attractiveness Analysis: Global Intravenous Access Devices Market, by Geography (2012)
FIG. 6 Comparative Analysis: Global Intravenous Access Devices Market, By Product Type, 2012 & 2019 (Value %)
FIG. 7 Global Intravenous Needles Market Revenue, 2011 – 2019 (USD Billion)
FIG. 8 Global Midline Peripheral Catheter Market Revenue, 2011 – 2019 (USD Billion)
FIG. 9 Global Peripherally Inserted Central Catheter Market Revenue, 2011 – 2019 (USD Billion)
FIG. 10 Global Centrally Inserted Central Catheter Market Revenue, 2011 – 2019 (USD Billion)
FIG. 11 Global Intravenous Insulin infusion Pumps Market Revenue, 2011 – 2019 (USD Billion)
FIG. 12 Global Parenteral Infusion Pumps Market Revenue, 2011 – 2019 (USD Billion)
FIG. 13 Global Patient Controlled Analgesia (PCA) Infusion Pumps Market Revenue, 2011 – 2019 (USD Billion)
FIG. 14 Global Syringe Infusion Pumps Market Revenue, 2011 – 2019 (USD Billion)
FIG. 15 Comparative Analysis: Global Intravenous Access Devices Market, By Geography, 2012 & 2019 (Value %)
FIG. 16 North America Intravenous Access Devices Market Revenue, 2011 – 2019 (USD Billion)
FIG. 17 Europe Intravenous Access Devices Market Revenue, 2011 – 2019 (USD Billion)
FIG. 18 Asia-Pacific Intravenous Access Devices Market Revenue, 2011 – 2019 (USD Billion)
FIG. 19 Rest of the World (RoW) Intravenous Access Devices Market Revenue, 2011 – 2019 (USD Billion)
FIG. 20 Market Share by Key Players, 2012 (%)
FIG. 21 Baxter International: Annual Revenues, 2010 – 2012 (USD Million)
FIG. 22 B. Braun Melsungen AG: Annual Sales, 2010 – 2012 (USD Million)
FIG. 23 Becton, Dickinson and Company: Annual Revenues, 2010 – 2012 (USD Million)
FIG. 24 CareFusion Corporation: Annual Revenues, 2010 - 2012 (USD Million)
FIG. 25 Covidien Plc: Annual Revenues, 2010 – 2012 (USD Million)
FIG. 26 Fresenius Medical Care AG & Co. KGaA: Annual Revenues, 2010 – 2012 (USD Million)
FIG. 27 Hospira, Inc., Annual Sales: 2010 – 2012 (USD Millions)
FIG. 28 Medtronic, Inc.: Annual Sales, 2010 – 2012 (USD Million)
FIG. 29 Smiths Medical: Annual Sales, 2010 – 2012 (USD Million)
FIG. 30 Teleflex Incorporated: Annual Revenue, 2010 – 2012 (USD Million)
